Showing results (91-100 of 185) with videos related to

Sort By:
Pageof 19
Journal of Crohn'S & Colitis|May 3, 2018
Systematic Review and Meta-Analysis: Preoperative Vedolizumab Treatment and Postoperative Complications in Patients with Inflammatory Bowel DiseaseCindy C Y Law, Alisha Narula, Amy L Lightner, et al.
Journal of Crohn'S & Colitis|November 9, 2025
Addition of baseline histology and fecal calprotectin does not reduce placebo rates in ulcerative colitis clinical trials: post-hoc analysis of patient-level dataEmily C L Wong, John K Marshall, Christopher Ma, et al.
The American Journal of Gastroenterology|July 26, 2024
Using Diet to Treat Inflammatory Bowel Disease: A Systematic ReviewAlexandra Gleave, Aryan Shah, Umair Tahir, et al.
Inflammatory Bowel Diseases|August 13, 2024
Comparative Efficacy of Biologics and Small Molecule Therapies in Improving Patient-Reported Outcomes in Ulcerative Colitis: Systematic Review and Network Meta-AnalysisMohammad Shehab, Amro Hassan, Fatema Alrashed, et al.
Inflammatory Bowel Diseases|July 28, 2023
Early Biologic Treatment Decreases Risk of Surgery in Crohn's Disease but not in Ulcerative Colitis: Systematic Review and Meta-AnalysisCindy C Y Law, Bryce Tkachuk, Stephen Lieto, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 5, 2026
Comparing Onset of Efficacy of Biologic and Small Molecule Therapies in Biologic-Naïve Ulcerative Colitis: A Post-hoc AnalysisEmily C L Wong, Vipul Jairath, Parambir S Dulai, et al.
The American Journal of Gastroenterology|September 29, 2021
A Microsimulation Model to Determine the Cost-Effectiveness of Treat-to-Target Strategies for Crohn's DiseaseParambir S Dulai, Vipul Jairath, Neeraj Narula, et al.
United European Gastroenterology Journal|June 2, 2021
The impact of ustekinumab on extraintestinal manifestations of Crohn's disease: A post hoc analysis of the UNITI studiesNeeraj Narula, Achuthan Aruljothy, Emily C L Wong, et al.
European Journal of Gastroenterology & Hepatology|December 4, 2025
Patients with ulcerative colitis that have endoscopic Mayo score 1 and active histologic inflammation have similar outcomes to mild-moderate patients with Mayo score 2: a post hoc analysis of the VARSITY trialEmily C L Wong, Nazmus Khan, Parambir S Dulai, et al.
The American Journal of Gastroenterology|February 2, 2026
Infliximab and Upadacitinib Demonstrate Superior Early Onset of Efficacy in Biologic-Naïve Ulcerative Colitis with Severe Endoscopic DiseaseEmily C L Wong, Vipul Jairath, Parambir S Dulai, et al.
Pageof 19